Abstract | OBJECTIVE: The objective was to test a bispecific ligand-directed toxin (BLT), with reduced immunogenicity for enhanced efficacy in targeting orthotopic pancreatic cancer in vivo. METHOD: RESULTS: Deimmunized EGF4KDEL was significantly effective after systemic injection against established orthotopic MIA PaCa-2 pancreatic cancer and selectively prevented metastasis. Mutagenesis significantly reduced antitoxin levels in vivo with no apparent activity loss in vitro. The drug was effective against 3 human pancreatic cancer lines in vitro, MIA PaCa-2, SW1990, and S2VP10. CONCLUSIONS: Despite the metastatic nature of the MIA PaCa-2 orthotopic tumor xenografted in nude mice, high percentages of tumors responded to extended dEGFKDEL treatment resulting in significant anticancer effects and disease-free survivors.
|
Authors | Seunguk Oh, Deborah A Todhunter, Angela Panoskaltsis-Mortari, Donald J Buchsbaum, Shoko Toma, Daniel A Vallera |
Journal | Pancreas
(Pancreas)
Vol. 41
Issue 5
Pg. 789-96
(Jul 2012)
ISSN: 1536-4828 [Electronic] United States |
PMID | 22258068
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Bispecific
- Antineoplastic Agents
- Exotoxins
- Immunotoxins
- Ligands
- Interleukin-4
- Epidermal Growth Factor
|
Topics |
- Amino Acid Sequence
- Animals
- Antibodies, Bispecific
(immunology, pharmacology)
- Antineoplastic Agents
(immunology, pharmacology)
- Cell Line, Tumor
- Epidermal Growth Factor
(genetics, immunology)
- Exotoxins
(genetics, immunology)
- Humans
- Immunotoxins
(genetics, immunology, pharmacology)
- Interleukin-4
(genetics, immunology)
- Ligands
- Male
- Mice
- Mice, Nude
- Mutation
- Pancreatic Neoplasms
(drug therapy, immunology, pathology)
- Pseudomonas
(genetics, immunology)
- Time Factors
- Tumor Burden
(drug effects, immunology)
- Xenograft Model Antitumor Assays
|